Advertisement

Journal of Cell Communication and Signaling

, Volume 13, Issue 3, pp 407–420 | Cite as

Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer

  • Priyanka Ray
  • Gauthami Nair
  • Arnab Ghosh
  • Snigdha Banerjee
  • Mikhail Y. Golovko
  • Sushanta K. BanerjeeEmail author
  • Katie M. Reindl
  • Sanku Mallik
  • Mohiuddin QuadirEmail author
Research Article
  • 129 Downloads

Abstract

Limited effectiveness of Raf and MEK inhibitors has impelled the interest to use the inhibitors of Extra-cellular Receptor Kinase (ERK) pathway in combination with Gemcitabine (GEM) in pancreatic cancer. However, off-target abundance of ERK receptors, challenging physico-chemical properties, and dose-limiting toxicity of the inhibitor has presented critical challenges towards fabricating this combination amenable for clinical translation. Herein we report a pharmaceutical nanoformulation of GEM and an ERK inhibitor (SCH 772984) co-stabilized within a pH-sensing nanocarrier (NC, with a hydrodynamic diameter of 161 ± 5.0 nm). The NCs were modularly derived from a triblock, self-assembling copolymer, and were chemically conjugated with GEM and encapsulated with SCH772984 at a loading content of 20.2% and 18.3%, respectively. Through pH-mediated unfolding of the individual blocks of the copolymer, the NCs were able to control the release of encapsulated drugs, traffic through cellular membranes, engage target receptors, suppress proliferation of pancreatic cancer cells, and accumulate at disease sites. Collectively our studies showed the feasibility of co-delivery of a combination chemotherapy consisting of GEM and an ERK inhibitor from a NC platform, which can sense and respond to tumor microenvironment of pancreatic cancer setting.

Keywords

Extracellular Receptor Kinase (ERK) Pancreatic cancer Nanocarrier Drug delivery 

Notes

Acknowledgments

This research was supported by NIH grant number 1P20 GM109024 from the National Institute of General Medical Sciences (NIGMS). TEM material is based upon work supported by the NSF under Grant No. 0923354. Funding for the Core Biology Facility used in this publication was made possible by NIH Grant Number 2P20 RR015566 from the National Center for Research Resources. MS analysis was supported through NIH funded COBRE Mass Spec Core Facility Grant 5P30GM103329-05. SM acknowledges the support through the NIH grant 1R01 GM 114080 (NIGMS). Partial support for this work was received from NSF Grant No. IIA-1355466 from the ‘North Dakota Established Program to Stimulate Competitive Research (EPSCoR)’ through the Center for Sustainable Materials Science. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Any opinions, findings, and conclusions or recommendations expressed are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The work is partially supported by Merit review grant from Department of Veterans Affairs (Sushanta K. Banerjee, 5I01BX001989-04 and Snigdha Banerjee, I01BX001002-05), KUMC Lied Basic Science Grant Program (SKB), and Grace Hortense Greenley Trust, directed by The Research Foundation in memory of Eva Lee Caldwell (SKB). We thank S. Golovko for her excellent assistance with MS analysis.

Supplementary material

12079_2019_514_MOESM1_ESM.docx (2.8 mb)
ESM 1 (DOCX 2874 kb)

References

  1. Alabi CA, Love KT, Sahay G, Yin H, Luly KM, Langer R, Anderson DG (2013) Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery. Proc Natl Acad Sci 110:12881–12886CrossRefGoogle Scholar
  2. Bae Y, Nishiyama N, Kataoka K (2007) In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug Chem 18:1131–1139CrossRefGoogle Scholar
  3. Chan WW, Chhowalla M, Glotzer S, Gogotsi Y, Hafner JH, Hammond PT, Hersam MC, Javey A, Kagan CR, Khademhosseini A, Kotov NA, Lee ST, Li Y, Mohwald H, Mulvaney PA, Nel AE, Nordlander PJ, Parak WJ, Penner RM, Rogach AL, Schaak RE, Stevens MM, Wee AT, Willson CG, Fernandez LE, Weiss PS (2016) Nanoscience and nanotechnology impacting diverse fields of science, engineering, and medicine. ACS Nano 10:10615–10617CrossRefGoogle Scholar
  4. Chen L, Zhou D, Liu Z, Huang X, Liu Q, Kang Y, Chen Z, Guo Y, Zhu H, Sun C (2018) Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway. Oncol Rep 39:1081–1089Google Scholar
  5. Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux M, Unicancer, G. T. D. o. and Intergroup, P (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–1825CrossRefGoogle Scholar
  6. Cruz-Monserrate Z, Roland CL, Deng D, Arumugam T, Moshnikova A, Andreev OA, Reshetnyak YK, Logsdon CD (2014) Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep 4:4410CrossRefGoogle Scholar
  7. Dan K, Bose N, Ghosh S (2011) Vesicular assembly and thermo-responsive vesicle-to-micelle transition from an amphiphilic random copolymer. Chem Commun 47:12491–12493CrossRefGoogle Scholar
  8. Daquinag AC, Souza GR, Kolonin MG (2013) Adipose tissue engineering in three-dimensional levitation tissue culture system based on magnetic nanoparticles. Tissue Eng Part C Methods 19:336–344CrossRefGoogle Scholar
  9. Delitto D, Black BS, Sorenson HL, Knowlton AE, Thomas RM, Sarosi GA, Moldawer LL, Behrns KE, Liu C, George TJ, Trevino JG, Wallet SM, Hughes SJ (2015) The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival. BMC Cancer 15:783CrossRefGoogle Scholar
  10. Desai PK, Tseng H, Souza GR (2017) Assembly of hepatocyte spheroids using magnetic 3D cell culture for CYP450 inhibition/induction. Int J Mol Sci 18Google Scholar
  11. Dreaden EC, Kong YW, Morton SW, Correa S, Choi KY, Shopsowitz KE, Renggli K, Drapkin R, Yaffe MB, Hammond PT (2015) Tumor-targeted synergistic blockade of MAPK and PI3K from a layer-by-layer nanoparticle. Clin Cancer Res 21:4410–4419CrossRefGoogle Scholar
  12. Engler A, Bonner D, Buss H, Cheung E, Hammond P (2011) The synthetic tuning of clickable pH responsive cationic polypeptides and block copolypeptides. Soft Matter 7:5627–5637CrossRefGoogle Scholar
  13. Engler A, Chan J, Coady D, O'Brien J, Sardon H, Nelson A, Sanders D, Yang Y, Hedrick J (2013) Accessing new materials through polymerization and modification of a polycarbonate with a pendant activated Ester. Macromolecules 46:1283–1290CrossRefGoogle Scholar
  14. Engler AC, Lee HI, Hammond PT (2009) Highly efficient "grafting onto" a polypeptide backbone using click chemistry. Angew Chem Int Ed Eng 48:9334–9338CrossRefGoogle Scholar
  15. Fryer RA, Barlett B, Galustian C, Dalgleish AG (2011) Mechanisms underlying gemcitabine resistance in pancreatic cancer and sensitisation by the iMiD™ lenalidomide. Anticancer Res 31:3747–3756Google Scholar
  16. Gao W, Chan JM, Farokhzad OC (2010) pH-responsive nanoparticles for drug delivery. Mol Pharm 7:1913–1920CrossRefGoogle Scholar
  17. Germann U, Furey B, Roix J, Marklan W, Hoover R, Aronov A, Hale M, Chen G, Martinez-Botella G, Alargova R (2015) The selective ERK inhibitor BVD-523 is active models of MAPK pathway-dependent cancers, including those with intrinsic and acquired drug resistance. In 106th annual meeting of the American Association for Cancer Research. Cancer Res 75:4693Google Scholar
  18. Gourgou-Bourgade S, Bascoul-Mollevi C, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Boige V, Bérille J, Conroy T (2013) Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial. J Clin Oncol 31:23–29CrossRefGoogle Scholar
  19. Haisler WL, Timm DM, Gage JA, Tseng H, Killian TC, Souza GR (2013) Three-dimensional cell culturing by magnetic levitation. Nat Protoc 8:1940–1949CrossRefGoogle Scholar
  20. Hatzivassiliou G, Liu B, O'Brien C, Spoerke JM, Hoeflich KP, Haverty PM, Soriano R, Forrest WF, Heldens S, Chen H, Toy K, Ha C, Zhou W, Song K, Friedman LS, Amler LC, Hampton GM, Moffat J, Belvin M, Lackner MR (2012) ERK inhibition overcomes acquired resistance to MEK inhibitors. Mol Cancer Ther 11:1143–1154CrossRefGoogle Scholar
  21. Hayes TK, Neel NF, Hu C, Gautam P, Chenard M, Long B, Aziz M, Kassner M, Bryant KL, Pierobon M, Marayati R, Kher S, George SD, Xu M, Wang-Gillam A, Samatar AA, Maitra A, Wennerberg K, Petricoin EF, Yin HH, Nelkin B, Cox AD, Yeh JJ, Der CJ (2016) Long-term ERK inhibition in KRAS-mutant pancreatic Cancer is associated with MYC degradation and senescence-like growth suppression. Cancer Cell 29:75–89CrossRefGoogle Scholar
  22. Hou S, Tiriac H, Sridharan BP, Scampavia L, Madoux F, Seldin J, Souza GR, Watson D, Tuveson D, Spicer TP (2018) Advanced development of primary pancreatic organoid tumor models for high-throughput phenotypic drug screening. SLAS Discov 23:574–584Google Scholar
  23. Hu YB, Dammer EB, Ren RJ, Wang G (2015) The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration. Transl Neurodegener 4:18CrossRefGoogle Scholar
  24. Itaka K, Kanayama N, Nishiyama N, Jang W, Yamasaki Y, Nakamura K, Kawaguchi H, Kataoka K (2004) Supramolecular nanocarrier of siRNA from PEG-based block catiomer carrying diamine side chain with distinctive pK(a) directed to enhance intracellular gene silencing. J Am Chem Soc 126:13612–13613CrossRefGoogle Scholar
  25. Kulkarni P, Haldar M, Katti P, Dawes C, You S, Choi Y, Mallik S (2016) Hypoxia responsive, tumor penetrating lipid nanoparticles for delivery of chemotherapeutics to pancreatic Cancer cell spheroids. Bioconjug Chem 27:1830–1838CrossRefGoogle Scholar
  26. Kwon EJ, Skalak M, Lo Bu R, Bhatia SN (2016) Neuron-targeted nanoparticle for siRNA delivery to traumatic brain injuries. ACS Nano 10:7926–7933CrossRefGoogle Scholar
  27. Lee Y, Fukushima S, Bae Y, Hiki S, Ishii T, Kataoka K (2007) A protein nanocarrier from charge-conversion polymer in response to endosomal pH. J Am Chem Soc 129:5362−+CrossRefGoogle Scholar
  28. Leonard F, Godin B (2016) 3D in vitro model for breast Cancer research using magnetic levitation and bioprinting method. Methods Mol Biol 1406:239–251CrossRefGoogle Scholar
  29. Lo JH, Hao L, Muzumdar MD, Raghavan S, Kwon EJ, Pulver EM, Hsu F, Aguirre AJ, Wolpin BM, Fuchs CS, Hahn WC, Jacks T, Bhatia SN (2018) iRGD-guided tumor-penetrating Nanocomplexes for therapeutic siRNA delivery to pancreatic Cancer. Mol Cancer Ther 17:2377–2388CrossRefGoogle Scholar
  30. Lu J, Owen SC, Shoichet MS (2011) Stability of self-assembled polymeric micelles in serum. Macromolecules 44:6002–6008CrossRefGoogle Scholar
  31. Ma X, Wang Y, Zhao T, Li Y, Su L, Wang Z, Huang G, Sumer B, Gao J (2014) Ultra-pH-sensitive Nanoprobe library with broad pH Tunability and fluorescence emissions. J Am Chem Soc 136:11085–11092CrossRefGoogle Scholar
  32. Mi P, Kokuryo D, Cabral H, Wu H, Terada Y, Saga T, Aoki I, Nishiyama N, Kataoka K (2016) A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy. Nat Nanotechnol 11:724–730CrossRefGoogle Scholar
  33. Molina JR, Hayashi Y, Stephens C, Georgescu MM (2010) Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia 12:453–463CrossRefGoogle Scholar
  34. Morris EJ, Jha S, Restaino CR, Dayananth P, Zhu H, Cooper A, Carr D, Deng Y, Jin W, Black S, Long B, Liu J, Dinunzio E, Windsor W, Zhang R, Zhao S, Angagaw MH, Pinheiro EM, Desai J, Xiao L, Shipps G, Hruza A, Wang J, Kelly J, Paliwal S, Gao X, Babu BS, Zhu L, Daublain P, Zhang L, Lutterbach BA, Pelletier MR, Philippar U, Siliphaivanh P, Witter D, Kirschmeier P, Bishop WR, Hicklin D, Gilliland DG, Jayaraman L, Zawel L, Fawell S, Samatar AA (2013) Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. Cancer Discov 3:742–750CrossRefGoogle Scholar
  35. Moxley JH, De Vita VT, Brace K, Frei E (1967) Intensive combination chemotherapy and X-irradiation in Hodgkin's disease. Cancer Res 27:1258–1263Google Scholar
  36. Neuzillet C, Hammel P, Tijeras-Raballand A, Couvelard A, Raymond E (2013) Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. Cancer Metastasis Rev 32:147–162CrossRefGoogle Scholar
  37. Noel P, Munoz R, Rogers GW, Neilson A, Von Hoff DD, Han H (2017) Preparation and metabolic assay of 3-dimensional spheroid co-cultures of pancreatic cancer cells and fibroblasts. J Vis Exp 126(e56081):1-8Google Scholar
  38. Poon Z, Chen S, Engler AC, Lee HI, Atas E, von Maltzahn G, Bhatia SN, Hammond PT (2010) Ligand-clustered "patchy" nanoparticles for modulated cellular uptake and in vivo tumor targeting. Angew Chem Int Ed Eng 49:7266–7270CrossRefGoogle Scholar
  39. Quadir MA, Morton SW, Deng ZJ, Shopsowitz KE, Murphy RP, Epps TH, Hammond PT (2014a) PEG-polypeptide block copolymers as pH-responsive endosome-solubilizing drug nanocarriers. Mol Pharm 11:2420–2430CrossRefGoogle Scholar
  40. Quadir MA, Morton SW, Deng ZJ, Shopsowitz KE, Murphy RP, Thomas H, Epps I, Hammond PT (2014b) PEG-polypeptide block copolymers as pH-responsive endosome solubilizing drug nanocarriers. Mol Pharm 11:2420–2430CrossRefGoogle Scholar
  41. Sanders D, Fukushima K, Coady D, Nelson A, Fujiwara M, Yasumoto M, Hedrick J (2010) A simple and efficient synthesis of functionalized cyclic carbonate monomers using a versatile Pentafluorophenyl Ester intermediate. J Am Chem Soc 132:14724–14726CrossRefGoogle Scholar
  42. Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30CrossRefGoogle Scholar
  43. Souza GR, Molina JR, Raphael RM, Ozawa MG, Stark DJ, Levin CS, Bronk LF, Ananta JS, Mandelin J, Georgescu M-M, Bankson JA, Gelovani JG, Killian TC, Arap W, Pasqualini R (2010) Three-dimensional tissue culture based on magnetic cell levitation. Nat Nanotechnol 5:291–296CrossRefGoogle Scholar
  44. Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7:163–172CrossRefGoogle Scholar
  45. Tseng H, Balaoing LR, Grigoryan B, Raphael RM, Killian TC, Souza GR, Grande-Allen KJ (2014) A three-dimensional co-culture model of the aortic valve using magnetic levitation. Acta Biomater 10:173–182CrossRefGoogle Scholar
  46. Tseng H, Gage JA, Haisler WL, Neeley SK, Shen T, Hebel C, Barthlow HG, Wagoner M, Souza GR (2016) A high-throughput in vitro ring assay for vasoactivity using magnetic 3D bioprinting. Sci Rep 6:30640CrossRefGoogle Scholar
  47. Wang Y, Wang C, Li Y, Huang G, Zhao T, Ma X, Wang Z, Sumer B, White M, Gao J (2017) Digitization of endocytic pH by hybrid ultra-pH-Sensitive nanoprobes at single-organelle resolution. Adv Mater 29:1-9Google Scholar
  48. Wang Y, Zhou K, Huang G, Hensley C, Huang X, Ma X, Zhao T, Sumer B, DeBerardinis R, Gao J (2014) A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals. Nat Mater 13:204–212CrossRefGoogle Scholar
  49. Yan L, Takehiko I, Horacio C, Jin KH, Ji-Hun S, Nobuhiro N, Hiroki O, Kensuke O, Kazunori K (2009) Charge-conversional Polyionic complex micelles—efficient Nanocarriers for protein delivery into cytoplasm. Angew Chem 121:5413–5416CrossRefGoogle Scholar
  50. Zhang XW, Ma YX, Sun Y, Cao YB, Li Q, Xu CA (2017) Gemcitabine in combination with a second cytotoxic agent in the first-line treatment of locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis. Target Oncol 12:309–321CrossRefGoogle Scholar
  51. Zhao T, Huang G, Li Y, Yang S, Ramezani S, Lin Z, Wang Y, Ma X, Zeng Z, Luo M, de Boer E, Xie X, Thibodeaux J, Brekken R, Sun X, Sumer B, Gao J (2017) A transistor-like pH nanoprobe for tumour detection and image-guided surgery. Nat Biomed Eng 1:1-20Google Scholar
  52. Zhao X, Poon Z, Engler AC, Bonner DK, Hammond PT (2012) Enhanced stability of polymeric micelles based on postfunctionalized poly (ethylene glycol)-b-poly (γ-propargyl L-glutamate): the substituent effect. Biomacromolecules 13:1315–1322CrossRefGoogle Scholar
  53. Zhou K, Wang Y, Huang X, Luby-Phelps K, Sumer B, Gao J (2011) Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. Angew Chem Int Ed 50:6109–6114CrossRefGoogle Scholar

Copyright information

© The International CCN Society 2019

Authors and Affiliations

  1. 1.Department of Coatings and Polymeric MaterialsNorth Dakota State UniversityFargoUSA
  2. 2.Cellular and Molecular Biology Program, Department of BiologyNorth Dakota State UniversityFargoUSA
  3. 3.Cancer Research UnitVA Medical CenterKansas CityUSA
  4. 4.Department of Pathology and Laboratory MedicineUniversity of Kansas Medical CenterKansas CityUSA
  5. 5.Department of Biomedical SciencesUniversity of North DakotaGrand ForksUSA
  6. 6.Department of Pharmaceutical SciencesNorth Dakota State UniversityFargoUSA

Personalised recommendations